Badgley Phelps Wealth Managers, LLC Gilead Sciences, Inc. Transaction History
Badgley Phelps Wealth Managers, LLC
- $4.44 Billion
- Q2 2025
A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 122,347 shares of GILD stock, worth $14.4 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
122,347
Previous 122,656
0.25%
Holding current value
$14.4 Million
Previous $13.7 Million
1.3%
% of portfolio
0.31%
Previous 0.34%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
2,326Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.98 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.46 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.42 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...